Skip to main content
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.080
+0.170 (8.90%)
At close: Apr 1, 2025, 4:00 PM
2.000
-0.080 (-3.85%)
After-hours: Apr 1, 2025, 4:15 PM EDT

Sunshine Biopharma Stock Forecast

SBFM's stock price has decreased by -98.31% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Sunshine Biopharma stock has a target of 15, which predicts an increase of 621.15% from the current stock price of 2.08.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $15 $15 $15 $15
Change +621.15% +621.15% +621.15% +621.15%
* Price targets were last updated on Dec 5, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Sunshine Biopharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25
Strong Buy 111
Buy 000
Hold 000
Sell 000
Strong Sell 000
Total 111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
David Bouchey
Aegis Capital
 Aegis Capital
Strong Buy
Reiterates
$15
 Strong Buy Reiterates $15 +621.15% Dec 5, 2024
David Bouchey
Aegis Capital
 Aegis Capital
Strong Buy
Initiates
$5,200
 Strong Buy Initiates $5,200 +249,900.00% Aug 7, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
38.54M
from 24.09M
Increased by 59.94%
Revenue Next Year
102.00M
from 38.54M
Increased by 164.69%
EPS This Year
-4.20
from -380.00
EPS Next Year
0.75
from -4.20
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
21.12K71.41K228.43K4.35M24.09M38.54M102.00M
Revenue Growth
-238.10%219.88%1,802.41%454.42%59.94%164.69%
EPS
-----380.00-4.200.75
EPS Growth
-------
Forward PE
------2.76
No. Analysts -----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 39.7M 105.0M
Avg 38.5M 102.0M
Low 37.0M 98.0M

Revenue Growth

Revenue Growth 20242025
High
64.6%
172.5%
Avg
59.9%
164.7%
Low
53.7%
154.3%

EPS Forecast

EPS 20242025
High -4.33 0.78
Avg -4.20 0.75
Low -4.04 0.73

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.